Form 4 for NEPH NEPHROS INC
Accepted 2023-08-15 00:00:00 ET · period of report 2023-08-14 · accession 0001062993-23-016523 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-15 | 2023-08-14+ | NEPH | Banks Robert R. Jr. | Pres, CEO, Dir | P - Purchase | $1.68 | +2,000 | 2,000 | New | +$3,361 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-14 | P | A | 99 | $1.50 | 99 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-15 | P | A | 1,901 | $1.69 | 2,000 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.73, inclusive. The reporting person undertakes to provide Nephros Inc., any security holder of Nephros Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the set range set forth in this footnote. |